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The Pou domain containing transcription factor
Oct4 is a well-established regulator of pluripo-
tency in the inner cell mass of the mammalian
blastocyst as well as in embryonic stem cells.
While it has been shown that the Oct4 gene is
inactivated through a series of epigenetic mod-
ifications following implantation, recent studies
have detected Oct4 activity in a variety of
somatic stem cells and tumor cells. Based on
these observations it has been suggested that
Oct4 may also function in maintaining self-
renewal of somatic stem cells and, in addition,
may promote tumor formation. We employed
a genetic approach to determine whether Oct4
is important for maintaining pluripotency in the
stem cell compartments of several somatic tis-
sues, including the intestinal epithelium, bone
marrow (hematopoietic and mesenchymal line-
ages), hair follicle, brain, and liver. Oct4 gene
ablation in these tissues revealed no abnormal-
ities in homeostasis or regenerative capacity.
We conclude that Oct4 is dispensable for both
self-renewal and maintenance of somatic stem
cells in the adult mammal.
INTRODUCTION
The transcriptional regulator Oct4 is a Pou domain con-
taining protein expressed in pluripotent embryonic cells
and cells of the germline where its inactivation results in
loss of pluripotency and apoptosis, respectively (Kehler
et al., 2004; Nichols et al., 1998). In embryonic stem (ES)
cells, Oct4, along with transcriptional coregulators Nanog
and Sox-2, orchestrates a program of gene activity that
suppresses differentiation while endowing self-renewalCell(Boyer et al., 2005; Loh et al., 2006; Wang et al., 2006).
Upon induction of differentiation, the Oct4 locus
undergoes a series of repressive epigenetic modifications
mediated by the histone methyltransferase G9a and the
de novo DNA methyltransferases DNMT3a/b (Feldman
et al., 2006). Recent studies have, however, shown that
Oct4 is active in a variety of somatic stem cell compart-
ments and in cultured multipotent somatic progenitor
cells, where it has been suggested to function in a manner
analogous to its role in ES cells (see Table S1 in the Sup-
plemental Data available with this article online). Consis-
tent with this possibility is the observation that ectopic
expression of Oct4 in mice harboring a single-copy, doxy-
cycline-inducible transgene is sufficient to prevent differ-
entiation of intestinal epithelium while concomitantly
stimulating expansion of the progenitor cell compartment
(Hochedlinger et al., 2005).
Oct4 gene expression in the adult has been most
frequently reported in the bone marrow of both humans
and mice, particularly in hematopoietic and mesenchymal
stem cells (HSCs and MSCs) (D’Ippolito et al., 2004, 2006;
Goolsby et al., 2003; Izadpanah et al., 2006; Jiang et al.,
2002; Johnson et al., 2005; Lamoury et al., 2006; Moriscot
et al., 2005; Nayernia et al., 2006; Pallante et al., 2007;
Pochampally et al., 2004; Ren et al., 2006), as well as in
various subpopulations of multipotent progenitors
(D’Ippolito et al., 2004, 2006; Jiang et al., 2002; Nayernia
et al., 2006; Pallante et al., 2007; Serafini et al., 2007;
Zhang et al., 2005). Additionally, Oct4 expression has
been detected in progenitor cells from other tissues, in-
cluding pancreatic islets (Wang et al., 2004), kidney
(Gupta et al., 2006; Sagrinati et al., 2006), peripheral blood
(Johnson et al., 2005; Romagnani et al., 2005; Tondreau
et al., 2005), mammary epithelium (Tai et al., 2005), endo-
metrium of the uterus (Cervello et al., 2006; Matthai et al.,
2006), thyroid (Thomas et al., 2006), lung (Ling et al., 2006),
brain (Davis et al., 2006; Okuda et al., 2004), liver (Beltrami
et al., 2007), dermis, and hair follicles (Dyce et al., 2004,
2006; Kues et al., 2005; Mongan et al., 2006; Redvers
et al., 2006; Yu et al., 2006). In addition to these tissues,Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc. 403
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Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 1. Regeneration of the Intestinal Epithelium after Villin-CreER-Mediated Oct4 Inactivation
(A) Schematic of the Oct4 conditional allele subjected to Cre-mediated recombination. Primer sets F1/R1a and F1/R1b were used for verification
of excision, detecting the 2-lox and 1-lox alleles, respectively. Primer set F2/R2 spanning exons 4 and 5 was used for qRT-PCR analysis.
(B) Schematic of the Oct4-EGFP reporter allele used to assess Oct4 gene activity.
(C) Hematoxylin- and eosin-stained paraffin sections of intestinal epithelium radio-ablated with 14 Gy g irradiation show cell death 3 days post-irra-
diation, followed by regeneration within 5 days and a morphologically normal crypt-villus structure 8 days after g irradiation.
(D) Ki67 staining of sections in (C) shows that the proliferative zone at the base of the villi undergoes cell-cycle arrest by 3 days post-g irradiation,
followed by increased proliferation at 5 days. Eight days after g irradiation, the proliferative zone returns to the normal state.
(E) Higher magnification of (A) showing cells with abnormal nuclear morphology consistent with apoptosis 3 days after g irradiation. Newly generated
crypt cells exhibit normal morphology with basal nuclei.
(F) PCR analysis of genomic DNA isolated from tail tip (TT) or intestinal epithelium (IE) after Villin-Cre activation and either 8 days after g irradiation
(g-IR) or 9 months after excision. Loss of the 2-lox (functional) allele and appearance of the 1-lox (inactive) allele indicate successful recombination.
The type I collagen locus is a loading control.404 Cell Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc.
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Oct4 Is Dispensable for Somatic Stem Cell FunctionTable 1. Cre-Expressing Mouse Lines Used for Tissue-Specific Oct4 Deletion
Cre Transgene/Affected Tissue Temporal Induction of Oct4 Excision Excision Efficiency
Villin-CreER/intestinal epithelium Tamoxifen inducible 100% (el Marjou et al., 2004)
Keratin15-CrePr1/hair follicle
bulge stem cells
Mifepristone (RU486) inducible 100% (Morris et al., 2004)
Mx1Cre/hematopoetic lineages Interferon (poly dI/dC) inducible 100% (Kuhn et al., 1995)
Mx1Cre/marrow stromal cells Interferon (poly dI/dC) inducible >95%
Mx1Cre/hepatocytes Interferon (poly dI/dC) inducible >90%
Nestin-Cre neural progenitor cells E9.5–E15.5 100% (Bates et al., 1999)a number of studies have reported Oct4 expression in
primary tumors, transformed cells, amniotic fluid, and
umbilical cord blood (see Table S1 for references). Given
its expression in a variety of normal tissues and trans-
formed cells, it has been suggested that Oct4 may not
only be crucial for the maintenance of pluripotency in
embryonic cells but may also play an important role for
the self-renewal of somatic stem cells and in maintaining
tissue homeostasis. The goal of the current study was to
test this hypothesis by deleting Oct4 from somatic stem
cell compartments in vivo.
RESULTS
To investigate a possible function of Oct4 expression in
somatic cells, we used a Cre-lox based recombination
approach to achieve tissue-specific inactivation of a con-
ditional Oct4 allele (Oct4-2lox, Figure 1A) (Kehler et al.,
2004). Oct4-2lox mice were crossed to mice carrying
tissue-specific or inducible Cre transgenes to inactivate
Oct4 in organs that have a well-defined somatic stem
cell population. We deleted Oct4 in the intestine, bone
marrow, brain, liver, and hair follicles because Oct4
expression has previously been documented in these tis-
sues (Table S1). The Cre transgenes that were used to
achieve cell-type-specific deletion ofOct4 in these tissues
are described in Table 1.
Intestinal Epithelium
Inactivation of Oct4 in the intestinal epithelium (including
progenitor cells residing in the intestinal crypt) was
achieved through the tamoxifen-induced activation of
a transgene encoding a Cre recombinase/estrogen recep-
tor fusion protein under transcriptional control of the Villin
promoter (Villin-CreER) (el Marjou et al., 2004) in 8-week-
old mice. Recombination of the Oct4-2lox allele was con-
firmed by Southern blot analysis (data not shown). Weight
gain was monitored in adult mice for a period of 9 months,
with no differences observed between control (Oct41lox/+,
transgenic) and Oct4 mutant (Oct41lox/1lox, transgenic)
mice (Figure S1). Histological analysis revealed a normalCelltissue architecture containing differentiated cell types
(Paneth and goblet cells), a normal distribution of prolifer-
ating cells marked by Ki67 expression, and an absence of
any Oct4-positive cells in the crypts (Figure S1). In order to
test the regenerative capacity of intestinal crypt progenitor
cells in the absence of Oct4, mice were subjected to a 14
Gy dose of g irradiation. This resulted in widespread apo-
ptosis and cell death coupled with a growth arrest within
3 days. Five days after g irradiation, intestinal progenitor
cells became highly proliferative in the presence or ab-
sence of Oct4, giving rise to new crypts that reestablished
a normal intestinal epithelium by the eighth day after irra-
diation (Figures 1C–1E). In order to exclude the possibility
that a small number of progenitor cells escaped recombi-
nation and were responsible for the observed regenera-
tion and maintenance of the intestinal epithelium, we
performed PCR analysis of the Oct4 genomic locus. This
analysis revealed no evidence of nonrecombined Oct4-
2lox alleles in the newly generated tissue (Figure 1F).
Finally, we examined Oct4 gene expression throughout
the time course of epithelial recovery after irradiation
and found little to no Oct4 mRNA. Oct4 expression in
the intestine was found to be 105 times lower in compari-
son to ES cells (Figure 1G). Further purification of crypt
progenitor cells by EDTA-based fractionation of intestinal
epithelium followed by gene expression analysis revealed
no preference for Oct4 expression at the base of the crypt
(Figure S1). These findings indicate that Oct4 function is
not required for maintenance of the intestinal stem cell
niche.
Mesenchymal Stem Cells
In order to examine the effects ofOct4 deletion in the bone
marrow, we employed an interferon-inducible Mx1-Cre
transgene (Table 1) (Kuhn et al., 1995; Schneider et al.,
2003). We confirmed that activation of Mx1-Cre resulted
in 100% recombination in the whole marrow by PCR anal-
ysis (Figure 2A). Subsequent separation of mesenchymal
and hematopoietic cells confirmed recombination in
both cell lineages (data not shown). MSCs known to give
rise to cells of chondrogenic, adipogenic, myogenic, and(G) Quantitative RT-PCR throughout the time course of intestinal regeneration. Data are displayed as average signal intensity ± SD relative to a control
lacking reverse transcriptase (RT).Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc. 405
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Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 2. Proliferative and Lineage Commitment Capacity of Bone Marrow-Derived MSCs after Mx1-Cre-Mediated Inactivation
of Oct4
(A) Complete excision of the conditional Oct4 allele was validated in whole bone marrow as described in Figure 1.
(B) MSC clonal colony formation assay 5 days after marrow isolation.
(C) MSC colonies do not exhibit any significant Oct4 immunoreactivity in comparison to ES cell colonies.
(D) MSCs isolated from control and Oct4 mutant bone marrow cultured under osteogenic conditions formed postconfluent multilayered nodules that
express the early osteogenic marker Alkaline Phosphatase (AP) (day 12). By 18 days of culture mature osteoblasts form mineralized extracellular
matrix detected by silver nitrate staining per the method of Von Kossa (VK).
(E) Quantitative RT-PCR analysis of Oct4 expression in primary whole marrow, proliferating MSCs, and differentiated osteoblasts as described in
Figure 1G.
(F) Chondrogenic, high-density micromass cultures of MSCs form negatively charged extracellular matrix stained by Alcian blue.406 Cell Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc.
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Oct4 Is Dispensable for Somatic Stem Cell Functionosteogenic lineages (Keating, 2006) were derived from
both control and mutant bone marrow. These cells, as
well as multipotent subpopulations of MSCs, have been
the most frequently cited source of Oct4 expression in
somatic tissues (Table S1). The proliferative capacity
and potential for lineage commitment of MSCs were
addressed using in vitro colony formation assays, osteo-
blast and chondrocyte differentiation assays. Individual
MSCs derived from both control and Oct4 mutant MSCs
were able to proliferate to form clonal colonies
(Figure 2B). Upon reaching confluence, these cells under-
went osteogenic differentiation in the presence of ascor-
bic acid and inorganic phosphate, forming multilayered
nodules containing mineralized extracellular matrix hall-
marks of mature osteoblasts (Figure 2D). NoOct4-positive
cells were observed during colony formation (Figure 2C).
Gene expression analysis throughout the time course of
osteogenic lineage commitment revealed no significant
Oct4 gene activity in whole marrow, proliferating MSCs,
or in differentiated osteoblasts (Figure 2E). Similarly,
Oct4 mutant MSCs were able to activate Sox9 gene
expression and enter the chondrogenic lineage in BMP-
treated micromass cultures (Figure 2F and Figure S2).
Hematopoietic Lineages
Oct4 function was addressed in the well-defined HSC
(Kondo et al., 2003). Examination of the peripheral blood
circulation of control and Oct4 mutant mice 5, 12, and
35 days after Mx1-Cre induced recombination revealed
no deficiency in the ability ofOct4mutant mice to maintain
white blood cell (WBC), red blood cell (RBC), or platelet
counts at control levels throughout the experiment (Fig-
ures 3A and 3B). Flow cytometric analysis of the bone
marrow for monocyte, B cell, and granulocyte lineages
at 12 and 35 days after recombination showed little differ-
ence in the representation of these cell types between
control and Oct4 mutant animals (Figure 3C and data
not shown). Furthermore, Oct4 deletion did not affect
the lineage-negative, c-kit+, sca1+ population of HSCs
in the bone marrow (Figure 3D) (Camargo et al., 2006).
Subsequent analysis of Flt3-negative long-term HSCs
and Flt3-positive short-term HSCs showed no variation
in these populations in the absence of Oct4 (data not
shown). Quantitative RT-PCR (qRT-PCR) analysis of
flow-sorted HSCs, common lymphoid progenitors, granu-
locytes, and monocytes revealed no preference for Oct4
expression in stem cells, and expression in all of these
cell types was negligible in comparison to ES cells
(Figure S2). PCR analysis for the 2-lox and recombined
1-lox Oct4 alleles 8 weeks after Mx1-Cre activation veri-
fied the persistence of Oct4 null cells in the marrow, ruling
out potential functional contribution of any cells escaping
Cre-mediated recombination (Figure 3E). Ultimately, we
tested the regenerative potential of the HSCs by perform-
ing a competitive reconstitution assay in which equal num-
bers of either control or Oct4 mutant marrow cells bearing
a CD45.1 cell surface antigen were isolated 5 days after
Mx1-Cre activation and coinjected along with CD45.2
competitor cells into lethally irradiated recipient mice.CelThe CD45.1 and CD45.2 cells were allowed to compete
for reestablishment of the recipient’s hematopoietic sys-
tem, and the relative contribution of each donor cell was
assessed (Figure 3F). We found no significant differences
in the ability of control or Oct4 mutant cells to repopulate
the ablated hematopoietic systems of recipient animals.
Moreover, the observed reconstitution was stable over
time, demonstrating that HSCs lacking functional Oct4
alleles fully retain long-term pluripotency.
Liver
While a clearly defined stem cell niche has not been iden-
tified in the liver, several candidate progenitor cells have
been described (Walkup and Gerber, 2006) and Oct4
has been observed in liver-derived stem cells (Beltrami
et al., 2007). To test whether Oct4 functions in liver regen-
eration, we performed partial hepatectomies after inacti-
vation ofOct4 usingMx1-Cre (Kuhn et al., 1995; Schneider
et al., 2003) (Figure 4A). Two months after removal of 75%
of the liver, both control and Oct4 mutant mice were able
to fully regenerate lost tissue. The newly generated liver
was histologically normal, containing mature hepatocytes,
bile ducts, and vascularization (Figure 4B). In addition,
Oct4 protein was undetectable by immunostaining and
little to no Oct4 mRNA was expressed in the regenerated
liver (Figures 4C and 4D). As in the intestinal epithelium,
the newly regenerated liver of Oct4 mutant mice lacked
nonrecombinedOct4-2lox alleles (Figure 4E), demonstrat-
ing that cells lacking functional Oct4 alleles are capable of
tissue regeneration.
Brain
The Oct4 zebrafish ortholog spiel ohne grenzen (spg) has
been shown to be necessary for formation of the mid- and
hindbrain (Belting et al., 2001), and cultures of mammalian
neural progenitors exhibit Oct4 expression (Davis et al.,
2006; Okuda et al., 2004). We therefore examined the ef-
fect ofOct4 deletion in neural progenitor cells. A paternally
transmitted Nestin-Cre transgene was used to excise the
Oct4 conditional allele in all neural progenitor cells of the
developing brain (Table 1) (Bates et al., 1999; Fan et al.,
2001).Oct4mutant mice exhibited no apparent behavioral
abnormalities and brain morphology appeared normal
more than one year after Oct4 deletion (Figure 5A). Ki67-
positive neural stem cells were seen in the subventricular
zone of the lateral ventricles of both control and Oct4
mutant mice (Figures 5A and 5B). Oct4 expression in
this region was undetectable by immunostaining (Figures
5A and 5B), and Oct4 mRNA was nearly undetectable in
both control and mutant brain extract, embryonic day 13
brain extract, as well as in purified primary cultures of
neural progenitor cells (Figure 5C).
Hair Follicle
The function of Oct4 was examined in the hair follicle
through activation of a Keratin1-15 CrePr1 transgene
(K15-CrePr1). This transgene encodes a Cre-progester-
one receptor fusion protein and is expressed exclusively
in the hair follicle bulge stem cells (Morris et al., 2004).l Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc. 407
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Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 3. Hematopoietic Lineage Analysis in Mx1-Cre, Oct4 Conditional Mice
(A) Analysis of peripheral blood from control orOct4 mutant mice 5, 12, and 35 days after inactivation of theOct4 gene with Mx1-Cre. White blood cell
(WBC) and red blood cell (RBC) counts were unaffected in the absence of Oct4.
(B) Platelet counts 5, 12, and 35 days after Oct4 inactivation. Data are presented as mean ± SD, n = 5.
(C) Staining of whole marrow 35 days after Cre-mediated excision with hematopoietic lineage markers for granulocytes, monocytes, and B cells
isolated from bone marrow and analyzed by flow cytometry.
(D) HSC markers c-Kit and Sca1 allow for the visualization of c-Kit+, Sca1+ HSCs by flow cytometry gated on the lineage-negative (lin) fraction of
viable cells at 12 and 35 days after Oct4 inactivation. Data presented as mean ± SD, n = 3.
(E) Analysis of genomic DNA isolated from bone marrow (WM) 8 weeks after excision of the conditional Oct4 allele with Mx1-Cre demonstrating
stability of Oct4 null cells in the marrow. Tail tip genomic DNA (TT) shows nonrecombined controls.408 Cell Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc.
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Oct4 Is Dispensable for Somatic Stem Cell FunctionThese cells give rise to all differentiated cell types in the
follicle, enter the dermal lineage during wound healing
(Ito et al., 2005), and have previously been shown to ex-
press Oct4 (Yu et al., 2006). The hair follicles of 8-week-
old mice were examined after activation of K15-CrePr1
through dermal administration of the progesterone antag-
onist mifepristone. We observed differentiated cell types
and sebaceous glands in both control and Oct4 mutant
follicles (Figure 5D). Immunostaining with Oct4 and Ki67
antibodies revealed no Oct4-positive cells in or around
the follicle and a normal distribution of proliferating cells
(Figure 5D), and qRT-PCR analysis of mRNA isolated
from skin revealed no significant Oct4 expression relative
to ES cells (Figure 4D). To test the regenerative capacity of
the skin in control and Oct4 mutant mice, we performed
wound-healing assays in which 8 mm, full-thickness der-
mal biopsies were monitored for 2 weeks and found no
significant differences in wound-healing capacity
(Figure 5E). While recent studies have demonstrated that
an additional epidermal stem cell, which may or may not
have inactivated Oct4 in our model, can contribute to
wound healing and follicle formation after wounding, our
Oct4 K15-CrePr1 mice were able to continue hair growth
during homeostatic conditions, a process known to be de-
pendent on the K15-positive stem cells of the follicular
bulge (Morris et al., 2004).
Oct4 Expression in Somatic Cells
The results described thus far failed to reveal any func-
tional role for Oct4 in the homeostasis or regeneration of
a number of somatic tissues. Because Oct4 expression
in somatic tissues has been detected in stem cell popula-
tions by PCR or immunohistological methods in a number
of published reports (Table S1), we attempted to confirm
these observations using another approach. We gener-
ated a reporter allele through homologous recombination
in ES cells in which EGFP is expressed from the endoge-
nous Oct4 locus (Oct4-EGFP) (Figure 1B). The fidelity of
the reporter was confirmed by flow cytometric analysis
of targeted ES cells. Over 95% of Oct4-EGFP ES cells
strongly expressed EGFP, consistent with their pluripotent
state (Figure 6A). We subsequently generated mice from
Oct4-EGFP ES cells and examined EGFP expression at
the single cell level in a number of tissues. Flow cytometric
analysis of whole bone marrow containing multipotent
MSCs and HSCs revealed no EGFP-positive cell popula-
tion when compared to wild-type marrow (Figure 6B). Pu-
rification of c-kit+, sca1+, lineageHSCs derived from the
bone marrow confirmed the absence of Oct4-expressing
hematopoietic progenitors (Figure 6C). In addition to the
bone marrow, numerous other tissues, including liver,
brain, intestine, stomach, skeletal muscle, skin, lungs,
heart, spleen, kidney, bladder, thymus, and prostate
were examined using antibodies raised against EGFP
and positive signals were never observed, in contrast toCellteratomas derived from Oct4-EGFP ES cells, which
exhibit pockets of undifferentiated cells with strong GFP
expression (Figure S3 and data not shown). These find-
ings, coupled with the failure to detect Oct4 transcripts
by qRT-PCR, indicate that the endogenous Oct4 locus is
inactive in the adult mouse. Our results are consistent
with the Oct4 locus being effectively silenced in somatic
tissues and therefore dispensable for the maintenance of
somatic stem cells or tissue regeneration in the adult.
DISCUSSION
Oct4 expression in somatic stem cells and in various
cancer cells has been described in numerous recently
published reports (Table S1). This has led to the provoca-
tive proposition that Oct4 may be involved not only in the
maintenance of pluripotency in ES cells but also in the self-
renewal of somatic stem cells and in the genesis of can-
cers (Tai et al., 2005). To test this possibility, we deleted
the Oct4 gene in several tissues that have well-defined
stem cell compartments and a high rate of cell turnover.
Oct4 deletion in the intestine, bone marrow, hair follicle,
liver, or CNS had no effect on tissue maintenance or
injury-induced regeneration. Moreover, we observed no
significant expression of the Oct4 gene using immuno-
histochemistry, quantitative RT-PCR, or flow cytometric
analysis of cells harboring a targeted Oct4-EGFP reporter
allele.
While Oct4 is highly expressed in ES cells, it becomes
silenced upon differentiation through a two-step mecha-
nism in which histone H3 methylation precedes Dnmt3a/
3b-mediated promoter methylation (Feldman et al.,
2006).Oct4 activity does, however, persist in the germline,
where it is required for the viability of germ cells (Kehler
et al., 2004). Furthermore, Oct4 is frequently expressed
in tumors of germ cell origin, where it acts as an oncogenic
fate determinant (Gidekel et al., 2003; Looijenga et al.,
2003). It is significant for this discussion that ectopic acti-
vation of Oct4 in the intestine or skin results in rapid ex-
pansion of progenitor cells and invasive tumor formation
indicating that Oct4 can also act as a powerful oncogene
in somatic cells (Hochedlinger et al., 2005). If Oct4 func-
tioned in somatic stem cells and the Oct4 genomic locus
existed in a state permissible for transcriptional activation
in these cells, one might expect that it would be a fre-
quently activated oncogene in cancers of somatic origin.
This, however, does not seem to be the case. Looijenga
et al. examined the expression of Oct4 in over 3600 pri-
mary tumors representing more than 100 tumor types
and found Oct4 reactivity consistently in germ cell tumors,
but only in three tumors of somatic origin (Looijenga et al.,
2003). In these rare Oct4-expressing somatic tumors,
Oct4 expression could potentially be due to genomic
rearrangements transposing the Oct4 coding sequence
into the vicinity of active promoter regions rather than(F) Competitive reconstitution assay in which control or Oct4 mutant marrow cells were isolated 5 days after Mx1-Cre-mediated excision of Oct4 and
each injected into lethally irradiated recipient mice along with an equal number of isogenic competitor cells. Donor and competitor cells were isolated
from peripherial blood at 8 and 12 weeks after transplant and distinguished by CD45 isotypes. Data are presented as mean values ± SD, n = 10.Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc. 409
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Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 4. Liver Regeneration after Mx1-Cre-Mediated Inactivation of Oct4
(A) Outline of experimental design for liver regeneration in Oct4 mutant and control Mx1-Cre mice.
(B) Histological analysis of regenerated liver in the presence or absence of Oct4. Hematoxylin and eosin (H&E) staining at low (top panels) and high
(middle panels) magnification demonstrating normal liver architecture with well-formed hepatic lobules, bile ducts, and vessels after regeneration.
Ki67 staining (lower panels, arrows) showing a normal distribution of proliferating cells in regenerated liver 2 months after hepatectomy.
(C) Oct4 immunostaining of newly generated liver revealed no Oct4+ nuclei, however some non-specific staining of extracellular matrix was observed
in both control and mutant liver.
(D) qRT-PCR analysis of control and Oct4 mutant liver, skin, and brain reveals no significant Oct4 expression in comparison to ES cells. Data are
mean ± SD, relative to –RT, n = 3.
(E) PCR analysis of the Oct4 locus in genomic DNA isolated from tail tip (TT) or hepatic tissue 2 months after hepatectomy (Liv) showing the presence
of the mutant 1-lox allele and absence of the functional 2-lox allele. The type I collagen gene acts as a loading control.reactivation of endogenous Oct4 regulatory elements
(Yamaguchi et al., 2005). These observations are consis-
tent with the notion that the epigenetic mechanisms
silencing Oct4 in somatic tissues are highly effective and
that Oct4 is dispensable in the adult, and is only rarely
activated in somatic tumors.410 Cell Stem Cell 1, 403–415, October 2007 ª2007 Elsevier IncWhat then could be the significance of somatic Oct4
expression observed in numerous studies? We note that
the Oct4 expression levels described in many of these
studies were very low, usually detected only after 30–40
cycles of PCR amplification (Table S1). We confirmed
published results in that we were able to detect low levels.
Cell Stem Cell
Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 5. CNS Analysis in Oct4 Conditional, Nestin-Cre Mice and Hair Follicle Analysis in Oct4 Conditional, K15-CrePr1 Mice
(A) Coronal sections of control orOct4mutant brain isolated from 14-month-old mice reveal no gross morphological abnormalities. The subventricular
zone of the lateral ventricles reveals proliferating neural progenitor cells by Ki67 staining (arrows). Oct4 immunostaining revealed no positive nuclei;
however, nonspecific staining of vascularization was observed in both control and mutant brains.
(B) High magnification image of lateral ventricles described in (A).
(C) Quantitative RT-PCR analysis of Oct4 expression in control and mutant brain, wild-type embryonic day 13.5 brain, and two lines of ex vivo
cultured primary neural progenitor cell lines NP1 and NP2 revealed no significant Oct4 mRNA in any of these samples in comparison to ESCs.
Data are mean ± SD, relative to GAPDH, n = 3.
(D) Sections of control and K15-CrePr1Pr1 Oct4 mutant hair follicles show no Oct4+ nuclei but rather diffuse, nonspecific Oct4 staining in sebocytes
(center panels, arrowheads). Ki67 immunostaining of follicles shows proliferative cells in both control and mutant follicles (lower panels, arrows).
(E) Wound-healing assays in which 8 mm, full thickness dermal punches were monitored for 2 weeks, n = 3.of Oct4 message in various progenitor cells and somatic
tissue (including HSCs, MSCs, intestinal crypt progeni-
tors, and neuroprogenitors) by quantitative RT-PCR. The
amount of Oct4 detected was many fold lower than what
was observed in ES cells and present even in samplesCethat had genetically inactive Oct4 loci, raising the question
as to whether the observedOct4 expression is functionally
significant or merely represents the noise of the detection
method. Furthermore, the genome contains at least six
Oct4 pseudogenes, the expression of which couldll Stem Cell 1, 403–415, October 2007 ª2007 Elsevier Inc. 411
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Oct4 Is Dispensable for Somatic Stem Cell FunctionFigure 6. Oct4 Gene Expression in Bone Marrow and HSCs
(A) Flow cytometric analysis for GFP activity in control and Oct4-EGFP targeted ES cells.
(B) Oct4-EGFP activity in total bone marrow isolated from Oct4-EGFP mice showing no discernible differences in the number of GFP-positive cells.
(C) Oct4-EGFP activity in c-Kit+, Sca+, Lin HSCs is undetectable.potentially be mistaken for that of the endogenous Oct4
gene (Pain et al., 2005; Suo et al., 2005). In addition to
Oct4 pseudogenes, a number of Pou-domain family mem-
bers are expressed in somatic tissue, and similarities in
both gene and protein sequence may also contribute to
false detection of Oct4 in a number of assays. This caveat
is evident in the immunohistochemistry presented in the
current study. Using an Oct4 antibody, we were able to
detect positive cells in several tissues, particularly the
stroma of the intestine. It is clear that this staining is non-
specific, as it appeared in tissues lacking a functionalOct4
locus and was not reproducible when using expression
analysis or a GFP antibody in tissue sections isolated
from Oct4-GFP mice. This also raises the issue of func-
tional redundancy within the Oct family, such that the
observed lack of phenotype in Oct4 mutant tissue could
be due to compensation by other Oct proteins, although
we believe this possibility to be unlikely due to the evolu-
tionary divergence between Oct4 and these family mem-
bers. Finally, the detection of Oct4 expression in tumor
cell lines and in vitro cultures of tissue-derived cells may
be of little relevance to somatic stem cell function or
carcinogenesis in vivo. It is possible, for example, that
Oct4 gene activation in cultured cells is a rare event and412 Cell Stem Cell 1, 403–415, October 2007 ª2007 Elsevier InthatOct4-expressing cells may have a proliferative advan-
tage in culture. In summary, our data strongly argue that
Oct4, even if expressed at low levels in somatic cells, is
dispensable for the self-renewal of somatic stem cells,
for tissue homeostasis, and for the regeneration of tissue
in the adult.
EXPERIMENTAL PROCEDURES
Generation and Maintenance of Mice
Conditional Oct4 mice were maintained and genotyped as described
previously (Kehler et al., 2004). Nestin-Cre mice were maintained
and genotyped as previously described (Bates et al., 1999). In order
to achieve 100% recombination of the target allele in neural progenitor
cells, the imprinted Nestin-Cre transgene was passed through the
male germline. Mx1-Cre mice were obtained from Jackson Labs (Bar
Harbor, ME, USA). Activation of Mx1-Cre was achieved through five
consecutive daily intraperitoneal injections of 0.5 mg polyinosinic-
polycytidylic acid (poly dI/dC, Sigma, St. Louis, MO, USA). Partial
hepatectomies were performed after Mx1-Cre activation on 8-week-
old mice anesthetized with Avertin at a concentration of 0.5 mg/g. Re-
generated hepatic tissue was isolated after an 8 week period during
which mice were kept in sterile cages with antibiotic-containing water.
Villin-CreER mice were a generous gift from Dr. Sylvie Robine at the In-
stitut Curie, Paris, France. The Villin-CreER transgene was activated
through five consecutive daily intraperitoneal injections of tamoxifenc.
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Oct4 Is Dispensable for Somatic Stem Cell Function(1 mg in corn oil) (Sigma). K15-CrePr1Pr1 mice were a generous gift
from Dr. George Cotsarelis at the University of Pennsylvania, Philadel-
phia, PA, USA. The K15-CrePr1Pr1 transgene was activated through
administration of 1% w/w mifepristone (Sigma) in hand cream directly
to the dermis for five consecutive days. Dermal biopsies were per-
formed 1 to 2 weeks after K15-CrePr1Pr1 activation and monitored
for 2 weeks for wound-healing ability with a micrometer.
Oct4-GFP mice were generated by subcloning a 6.5 kb genomic
fragment encompassing exons 2–5 from a BAC library into Bluescript
via HindIII and EcoRI sites and termed pBS-Oct4. A loxP-flanked pgk-
Neo resistance cassette was cloned into the NotI site of pIRES-EGFP,
and subsequently the portion containing IRES-EGFP-floxed NEO
(lacking the polyA) was released via BamHI and EcoRV and subcloned
into the unique BclI site of pBS-Oct4 which lies between the stop
codon and the polyadenylation signal. The targeting construct was lin-
earized with SacII and electroporated into V6.5 ES cells. GFP-positive
colonies were picked and correct integration was verified by Southern
blot analysis on genomic DNA digested with BamHI and probed with
a fragment released from pBS-Oct4with HindIII and SacI (50 probe), re-
sulting in a 6 kb wild-type band and a 9 kb targeted band. Targeted ES
cells were transiently electroporated with Pac-Cre to eliminate the
floxed Neo cassette. Clones that had excised the neo cassette gave
a 7.4 kb band after digestion of genomic DNA with BamHI using the
50 probe. All animals were treated in accordance with IACUC guide-
lines under current approved protocols.
Histological Analysis
Isolated tissues were fixed in 4% paraformaldehyde in phosphate-
buffered saline (brain) or 10% phosphate-buffered formalin (all other
tissue) overnight and subsequently embedded in paraffin wax using
a Tissue-Tek VIP embedding machine (Miles Scientific, Napervielle,
IL) and a Thermo Shandon Histocenter 2 (Thermo Fisher Scientific,
Waltham, MA). Sections were cut at a thickness of 2 mm using a Leica
RM2065 (Leica, Wetzlar, Germany) and stained with hematoxylin and
eosin or antibodies against Oct4 or Ki67 as previously described (Ho-
chedlinger et al., 2005). Tissues isolated from mice harboring an induc-
ible Oct4 cDNA under control of the reverse tetracycline transactivator
were used as a positive control for Oct4 immunohistochemistry (Ho-
chedlinger et al., 2005).
For immunofluorescence, cells were fixed in a 6-well plate with 4%
PFA for 10 min. After one wash with PBS, the cells were blocked and
permeabilized in 5% FBS, 0.1% Triton-X for 15 min. Cells were subse-
quently incubated with a primary antibody against Oct4 at a 1:100
dilution for 1 hr at room temperature (rabbit polyclonal, H-134; Santa
Cruz Biotech, Santa Cruz, CA). After three washes with PBS, the cells
were incubated with an anti-rabbit secondary antibody labeled with
Cy3 for 1 hr in the dark. After a 5 min incubation with DAPI, the cells
were washed three times with PBS.
Tissue Isolation and Marrow Cell Culture
Total intestinal epithelium was dissociated using a solution of 3 mM
EDTA and 0.05 mM DTT for 30 min at room temperature. The muscu-
lature was discarded, and purified crypts/villi were used for DNA and
RNA isolation. Fractionation of the crypt-villus structure to enrich for
stem cells was performed as described in Ferraris et al. (1992). Abla-
tion of intestinal epithelium was achieved through g irradation of
mice in a Gammacell-40 Exactor Low-Dose Research Irradiator using
a dosage of 14 Gy. After irradiation, mice were monitored daily and
euthanized no more than 8 days after irradiation. Neural progenitor
cells were isolated by mechanical dissociation of E12.5 brains and
cultured on polyornithine-coated tissue culture plastic in N3 media
containing FGF and EGF (R&D Systems, Minneapolis, MN, USA) as de-
scribed in Gritti et al. (2001). Whole marrow was isolated from 8-week-
old mice from the femur and tibia after removal of the condyles at the
growth plate by flushing with a syringe and 30-gauge needle contain-
ing DMEM + 5% fetal calf serum (FCS) (HyClone, Thermo Fisher Scien-
tific). Whole marrow was separated into mesenchymal and hematopoi-
etic fractions through differential plating on tissue culture plates forCe72 hr in a-MEM supplemented with 15% FCS (HyClone). Colony for-
mation (CFU-F) assays were carried out by plating 4 3 106 nucleated
cells from freshly isolated whole marrow onto 10 cm plates and
allowed to expand for 5 days, at which time cultures were stained
with 0.1% Coomassie blue to identify colonies. For osteogenic differ-
entiation, MSCs were plated at a density of 106 cells/6-well plate and
allowed to proliferate until confluent, at which time osteogenesis was
initiated by the addition of ascorbic acid and b-glycerol phosphate to
the culture media (Owen et al., 1990). Alkaline phosphatase staining
and silver nitrate staining for mineral by the method of Von Kossa
were performed as previously described (Lengner et al., 2006). Chon-
drogenic differentiation of MSCs was carried out in high-density micro-
mass cultures in the presence of 100 ng/ml BMP2 (R&D Systems) and
analyzed as previously described (Lengner et al., 2004).
Hematopoietic Lineage Analysis and Flow Cytometry
For competitive reconstitution assays, C57Bl/6-CD45.1 recipient mice
were lethally irradiated (11 Gy) with g irradiation in a split dose, with 2 hr
between doses. The reconstituting cells were injected retro-orbitally
within 24 hr of irradiation. CD45.2 whole bone marrow cells (2 3 105)
from either control or Oct4 mutant mice were transplanted along
with the same dose of ‘‘competitor’’ cells from B6-CD45.1 animals.
Peripheral blood analysis was performed as previously described
(Camargo et al., 2006). At various time points after transplantation,
200 mL peripheral blood was collected from the retro-orbital plexus
of anesthetized transplant recipients. Erythrocytes were lysed and
nucleated cells were simultaneously stained with anti-CD45.1,
CD45.2, B220, Ly6G, and Mac1 antibodies. In order to identify
HSCs, BM was stained with antibodies against c-Kit, Sca-1, Flt3,
and a lineage cocktail (composed of CD3, B220, Ter119, Mac1, and
Gr-1 antibodies). All antibodies were obtained from Ebiosciences
(San Diego, CA). Stained blood and bone marrow samples were then
analyzed by flow cytometry using a two-laser instrument, FACSCalibur
(Becton Dickinson, Mountain View, CA), or sorted for subsequent RNA
purification at the MIT FACS facility using a FACS Aria (Becton Dickin-
son). Differential blood counts were obtained with a Hemavet 850
(Drew Scientific, Oxford, CT).
Quantitative RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA).
Five micrograms of total RNA was treated with DNase I to remove
potential contamination of genomic DNA using a DNA Free RNA kit
(Zymo Research, Orange, CA). One microgram of DNase I-treated
RNA was reverse transcribed using a First Strand Synthesis kit (Invitro-
gen) and ultimately resuspended in 100 ul of water. Quantitative PCR
analysis was performed in triplicate using 1/50 of the reverse transcrip-
tion reaction in an ABI Prism 7000 (Applied Biosystems, Foster City,
CA) with Platinum SYBR green qPCR SuperMix-UDG with ROX (Invi-
trogen). Primers used for Oct4 amplification were as follows: F,
50-ACATCGCCAATCAGCTTGG-30; R, 50-AGAACCATACTCGAACCA
CATCC-30. To ensure equal loading of cDNA into RT reactions, GAPDH
mRNA was amplified using the following: F, 50-TTCACCACCATGGAG
AAGGC-30; and R, 50-CCCTTTTGGCTCCACCCT-30. Data were
extracted from the linear range of amplification. All graphs of qRT-
PCR data shown represent samples of RNA that were DNase treated,
reverse transcribed, and amplified in parallel to avoid variation inherent
in these procedures.
Supplemental Data
Supplemental Data include one table and three figures and can be
found with this article online at http://www.cellstemcell.com/cgi/
content/full/1/4/403/DC1/.
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